CD8A and cancer: Furthermore, PD-L1 expression was significantly associated with high levels of tumoural CD8+ CTLs, γH2AX as a DSB marker, and IRF-1 as a transcriptional factor for PD-L1 in UC-associated dysplasia/colitic cancer compared with SCRC.